Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$56.4M |
| 2 |
Chemed
CHE
|
+$53.8M |
| 3 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$53.1M |
| 4 |
Petrobras
PBR
|
+$52.7M |
| 5 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMER
FIRSTMERIT CORP
FMER
|
+$58.7M |
| 2 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$38.2M |
| 3 |
PL
PROTECTIVE LIFE CORP
PL
|
+$37.8M |
| 4 |
Sally Beauty Holdings
SBH
|
+$36.2M |
| 5 |
TSMC
TSM
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.26% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.41% |
| 4 | Industrials | 7.4% |
| 5 | Consumer Discretionary | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Regal Rexnord
RRX
$13.5B
| $37.4M | 0.08% |
581,727
-7,410
| -1% | -$533K |
|
|
ESRX
152
DELISTED
Express Scripts Holding Company
ESRX
| $36.9M | 0.08% |
522,773
-70,658
| -12% | -$5.03M |
|
153
Pool Corp
POOL
$6.95B
| $36.1M | 0.08% |
670,252
-930
| -0.1% | -$51.8K |
|
154
Mitsubishi UFJ Financial
MUFG
$254B
| $36.1M | 0.08% |
6,431,632
-104,024
| -2% | -$607K |
|
155
United Parcel Service
UPS
$89.5B
| $35.9M | 0.08% |
365,069
-30,964
| -8% | -$3.08M |
|
156
NETGEAR
NTGR
$616M
| $35.3M | 0.08% |
1,130,289
-6,060
| -0.5% | -$200K |
|
|
MENT
157
DELISTED
Mentor Graphics Corp
MENT
| $34.8M | 0.07% |
1,697,773
+15,449
| +0.9% | +$330K |
|
158
Idacorp
IDA
$7.86B
| $34.3M | 0.07% |
639,977
-3,283
| -0.5% | -$181K |
|
159
Bio-Rad Laboratories Class A
BIO
$8.74B
| $33.2M | 0.07% |
293,171
-1,570
| -0.5% | -$186K |
|
160
Ecopetrol
EC
$35B
| $33.2M | 0.07% |
1,063,055
-67,045
| -6% | -$2.29M |
|
|
INVX
161
Innovex International
INVX
$1.85B
| $32.4M | 0.07% |
361,924
+7,600
| +2% | +$758K |
|
162
Polaris
PII
$3.88B
| $32.3M | 0.07% |
215,630
+2,671
| +1% | +$386K |
|
|
PVTB
163
DELISTED
PrivateBancorp Inc
PVTB
| $32.1M | 0.07% |
1,073,200
+43,257
| +4% | +$1.27M |
|
164
Plexus
PLXS
$6.47B
| $31.8M | 0.07% |
860,001
-6,120
| -0.7% | -$248K |
|
165
Acadia Realty Trust
AKR
$3.08B
| $31.3M | 0.07% |
1,134,561
+6,150
| +0.5% | +$175K |
|
166
Boeing
BA
$175B
| $31.2M | 0.07% |
244,637
-26,569
| -10% | -$3.35M |
|
167
Pegasystems
PEGA
$4.94B
| $27.9M | 0.06% |
2,922,100
+46,000
| +2% | +$497K |
|
|
EDR
168
DELISTED
Education Realty Trust Inc
EDR
| $27.3M | 0.06% |
885,904
-10,265
| -1% | -$331K |
|
169
Integra LifeSciences
IART
$1.33B
| $27.3M | 0.06% |
1,343,150
+41,076
| +3% | +$818K |
|
|
FIBG
170
DELISTED
CS FI Enhanced Big Cap Growth ETN
FIBG
| $26.8M | 0.06% |
528,239
-4,761
| -0.9% | -$241K |
|
171
Revvity
RVTY
$12.7B
| $26.8M | 0.06% |
614,529
+6,605
| +1% | +$301K |
|
172
Avista
AVA
$3.39B
| $26.6M | 0.06% |
871,315
-13,615
| -2% | -$434K |
|
173
Integer Holdings
ITGR
$3.42B
| $26M | 0.06% |
+668,700
| New | +$28.6M |
|
174
Biogen
BIIB
$30.7B
| $26M | 0.06% |
78,457
-10,428
| -12% | -$3.44M |
|
175
eBay
EBAY
$50.4B
| $25.8M | 0.06% |
1,084,081
-98,649
| -8% | -$2.19M |
|
Similar funds
Ken Fisher's Q3 2014 Portfolio in Review
As of Q3 2014, Ken Fisher held 645 positions worth $46.9B, down 1.4% from $47.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q3 2014 filing shows 47 new, 202 increased, 264 reduced and 61 closed positions. Its largest new stake was Chemed: 530,910 shares worth $54.6M. The largest sale was FIRSTMERIT CORP, an estimated $58.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q3 2014 buy was Chemed: 530,910 shares worth $54.6M.
- Ken Fisher added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2014, an estimated $56.4M increase.
- Ken Fisher's biggest Q3 2014 reduction was FIRSTMERIT CORP, cutting an estimated $58.7M.
- Ken Fisher fully exited PROTECTIVE LIFE CORP in Q3 2014, selling an estimated $37.8M.
- Ken Fisher's ten largest holdings make up 22% of its $46.9B portfolio in Q3 2014.
- Ken Fisher opened 47 new positions and closed 61 in Q3 2014.
- Ken Fisher's portfolio value fell 1.4% quarter-over-quarter to $46.9B.
Based on Fisher Asset Management's 13F filing for Q3 2014, filed 20 Oct 2014.